 | • レポートコード：MRC308GR11647 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界のカテーテル関連血流感染症治療の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のカテーテル関連血流感染症治療市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– カテーテル関連血流感染症治療の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
カテーテル関連血流感染症治療市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・抗菌剤、抗生物質
用途別セグメント
・病院、専門診療所、その他
主要な市場プレーヤー
・AstraZeneca、CorMedix, Inc.、Citus Pharmaceuticals、Fresenius Medical Care、Glenmark Pharmaceuticals Ltd.、Geistlich Pharma、Merck & Co., Inc.、Pfizer、TauroPhar GmbH、Xellia Pharmaceuticals Ltd.
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、カテーテル関連血流感染症治療製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なカテーテル関連血流感染症治療メーカーの企業概要、2019年～2022年までのカテーテル関連血流感染症治療の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なカテーテル関連血流感染症治療メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別カテーテル関連血流感染症治療の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのカテーテル関連血流感染症治療の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのカテーテル関連血流感染症治療市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびカテーテル関連血流感染症治療の産業チェーンを掲載しています。
・第14、15章では、カテーテル関連血流感染症治療の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– カテーテル関連血流感染症治療の概要
– 種類別分析（2018年vs2022年vs2029年）：抗菌剤、抗生物質
– 用途別分析（2018年vs2022年vs2029年）：病院、専門診療所、その他
– 世界のカテーテル関連血流感染症治療市場規模・予測
– 世界のカテーテル関連血流感染症治療生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– AstraZeneca、CorMedix, Inc.、Citus Pharmaceuticals、Fresenius Medical Care、Glenmark Pharmaceuticals Ltd.、Geistlich Pharma、Merck & Co., Inc.、Pfizer、TauroPhar GmbH、Xellia Pharmaceuticals Ltd.
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：抗菌剤、抗生物質
・用途別分析2018年-2029年：病院、専門診療所、その他
・カテーテル関連血流感染症治療の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・カテーテル関連血流感染症治療のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・カテーテル関連血流感染症治療のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・カテーテル関連血流感染症治療の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・カテーテル関連血流感染症治療の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Catheter-Associated Bloodstream Infection Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Catheter-Associated Bloodstream Infection Treatment Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Antibacterial Agents
1.3.3 Antibiotic
1.4 Market Analysis by Application
1.4.1 Overview: Global Catheter-Associated Bloodstream Infection Treatment Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Specialist Clinic
1.4.4 Other
1.5 Global Catheter-Associated Bloodstream Infection Treatment Market Size & Forecast
1.5.1 Global Catheter-Associated Bloodstream Infection Treatment Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Catheter-Associated Bloodstream Infection Treatment Sales Quantity (2018-2029)
1.5.3 Global Catheter-Associated Bloodstream Infection Treatment Average Price (2018-2029)
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Catheter-Associated Bloodstream Infection Treatment Product and Services
2.1.4 AstraZeneca Catheter-Associated Bloodstream Infection Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 AstraZeneca Recent Developments/Updates
2.2 CorMedix, Inc.
2.2.1 CorMedix, Inc. Details
2.2.2 CorMedix, Inc. Major Business
2.2.3 CorMedix, Inc. Catheter-Associated Bloodstream Infection Treatment Product and Services
2.2.4 CorMedix, Inc. Catheter-Associated Bloodstream Infection Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 CorMedix, Inc. Recent Developments/Updates
2.3 Citus Pharmaceuticals
2.3.1 Citus Pharmaceuticals Details
2.3.2 Citus Pharmaceuticals Major Business
2.3.3 Citus Pharmaceuticals Catheter-Associated Bloodstream Infection Treatment Product and Services
2.3.4 Citus Pharmaceuticals Catheter-Associated Bloodstream Infection Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Citus Pharmaceuticals Recent Developments/Updates
2.4 Fresenius Medical Care
2.4.1 Fresenius Medical Care Details
2.4.2 Fresenius Medical Care Major Business
2.4.3 Fresenius Medical Care Catheter-Associated Bloodstream Infection Treatment Product and Services
2.4.4 Fresenius Medical Care Catheter-Associated Bloodstream Infection Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Fresenius Medical Care Recent Developments/Updates
2.5 Glenmark Pharmaceuticals Ltd.
2.5.1 Glenmark Pharmaceuticals Ltd. Details
2.5.2 Glenmark Pharmaceuticals Ltd. Major Business
2.5.3 Glenmark Pharmaceuticals Ltd. Catheter-Associated Bloodstream Infection Treatment Product and Services
2.5.4 Glenmark Pharmaceuticals Ltd. Catheter-Associated Bloodstream Infection Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Glenmark Pharmaceuticals Ltd. Recent Developments/Updates
2.6 Geistlich Pharma
2.6.1 Geistlich Pharma Details
2.6.2 Geistlich Pharma Major Business
2.6.3 Geistlich Pharma Catheter-Associated Bloodstream Infection Treatment Product and Services
2.6.4 Geistlich Pharma Catheter-Associated Bloodstream Infection Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Geistlich Pharma Recent Developments/Updates
2.7 Merck & Co., Inc.
2.7.1 Merck & Co., Inc. Details
2.7.2 Merck & Co., Inc. Major Business
2.7.3 Merck & Co., Inc. Catheter-Associated Bloodstream Infection Treatment Product and Services
2.7.4 Merck & Co., Inc. Catheter-Associated Bloodstream Infection Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Merck & Co., Inc. Recent Developments/Updates
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Catheter-Associated Bloodstream Infection Treatment Product and Services
2.8.4 Pfizer Catheter-Associated Bloodstream Infection Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Pfizer Recent Developments/Updates
2.9 TauroPhar GmbH
2.9.1 TauroPhar GmbH Details
2.9.2 TauroPhar GmbH Major Business
2.9.3 TauroPhar GmbH Catheter-Associated Bloodstream Infection Treatment Product and Services
2.9.4 TauroPhar GmbH Catheter-Associated Bloodstream Infection Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 TauroPhar GmbH Recent Developments/Updates
2.10 Xellia Pharmaceuticals Ltd.
2.10.1 Xellia Pharmaceuticals Ltd. Details
2.10.2 Xellia Pharmaceuticals Ltd. Major Business
2.10.3 Xellia Pharmaceuticals Ltd. Catheter-Associated Bloodstream Infection Treatment Product and Services
2.10.4 Xellia Pharmaceuticals Ltd. Catheter-Associated Bloodstream Infection Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Xellia Pharmaceuticals Ltd. Recent Developments/Updates
3 Competitive Environment: Catheter-Associated Bloodstream Infection Treatment by Manufacturer
3.1 Global Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Manufacturer (2018-2023)
3.2 Global Catheter-Associated Bloodstream Infection Treatment Revenue by Manufacturer (2018-2023)
3.3 Global Catheter-Associated Bloodstream Infection Treatment Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Catheter-Associated Bloodstream Infection Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Catheter-Associated Bloodstream Infection Treatment Manufacturer Market Share in 2022
3.4.2 Top 6 Catheter-Associated Bloodstream Infection Treatment Manufacturer Market Share in 2022
3.5 Catheter-Associated Bloodstream Infection Treatment Market: Overall Company Footprint Analysis
3.5.1 Catheter-Associated Bloodstream Infection Treatment Market: Region Footprint
3.5.2 Catheter-Associated Bloodstream Infection Treatment Market: Company Product Type Footprint
3.5.3 Catheter-Associated Bloodstream Infection Treatment Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Catheter-Associated Bloodstream Infection Treatment Market Size by Region
4.1.1 Global Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Region (2018-2029)
4.1.2 Global Catheter-Associated Bloodstream Infection Treatment Consumption Value by Region (2018-2029)
4.1.3 Global Catheter-Associated Bloodstream Infection Treatment Average Price by Region (2018-2029)
4.2 North America Catheter-Associated Bloodstream Infection Treatment Consumption Value (2018-2029)
4.3 Europe Catheter-Associated Bloodstream Infection Treatment Consumption Value (2018-2029)
4.4 Asia-Pacific Catheter-Associated Bloodstream Infection Treatment Consumption Value (2018-2029)
4.5 South America Catheter-Associated Bloodstream Infection Treatment Consumption Value (2018-2029)
4.6 Middle East and Africa Catheter-Associated Bloodstream Infection Treatment Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Type (2018-2029)
5.2 Global Catheter-Associated Bloodstream Infection Treatment Consumption Value by Type (2018-2029)
5.3 Global Catheter-Associated Bloodstream Infection Treatment Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Application (2018-2029)
6.2 Global Catheter-Associated Bloodstream Infection Treatment Consumption Value by Application (2018-2029)
6.3 Global Catheter-Associated Bloodstream Infection Treatment Average Price by Application (2018-2029)
7 North America
7.1 North America Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Type (2018-2029)
7.2 North America Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Application (2018-2029)
7.3 North America Catheter-Associated Bloodstream Infection Treatment Market Size by Country
7.3.1 North America Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Country (2018-2029)
7.3.2 North America Catheter-Associated Bloodstream Infection Treatment Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Type (2018-2029)
8.2 Europe Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Application (2018-2029)
8.3 Europe Catheter-Associated Bloodstream Infection Treatment Market Size by Country
8.3.1 Europe Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Country (2018-2029)
8.3.2 Europe Catheter-Associated Bloodstream Infection Treatment Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Catheter-Associated Bloodstream Infection Treatment Market Size by Region
9.3.1 Asia-Pacific Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Catheter-Associated Bloodstream Infection Treatment Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Type (2018-2029)
10.2 South America Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Application (2018-2029)
10.3 South America Catheter-Associated Bloodstream Infection Treatment Market Size by Country
10.3.1 South America Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Country (2018-2029)
10.3.2 South America Catheter-Associated Bloodstream Infection Treatment Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Catheter-Associated Bloodstream Infection Treatment Market Size by Country
11.3.1 Middle East & Africa Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Catheter-Associated Bloodstream Infection Treatment Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Catheter-Associated Bloodstream Infection Treatment Market Drivers
12.2 Catheter-Associated Bloodstream Infection Treatment Market Restraints
12.3 Catheter-Associated Bloodstream Infection Treatment Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Catheter-Associated Bloodstream Infection Treatment and Key Manufacturers
13.2 Manufacturing Costs Percentage of Catheter-Associated Bloodstream Infection Treatment
13.3 Catheter-Associated Bloodstream Infection Treatment Production Process
13.4 Catheter-Associated Bloodstream Infection Treatment Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Catheter-Associated Bloodstream Infection Treatment Typical Distributors
14.3 Catheter-Associated Bloodstream Infection Treatment Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Catheter-Associated Bloodstream Infection Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Catheter-Associated Bloodstream Infection Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Major Business
Table 5. AstraZeneca Catheter-Associated Bloodstream Infection Treatment Product and Services
Table 6. AstraZeneca Catheter-Associated Bloodstream Infection Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. AstraZeneca Recent Developments/Updates
Table 8. CorMedix, Inc. Basic Information, Manufacturing Base and Competitors
Table 9. CorMedix, Inc. Major Business
Table 10. CorMedix, Inc. Catheter-Associated Bloodstream Infection Treatment Product and Services
Table 11. CorMedix, Inc. Catheter-Associated Bloodstream Infection Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. CorMedix, Inc. Recent Developments/Updates
Table 13. Citus Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Citus Pharmaceuticals Major Business
Table 15. Citus Pharmaceuticals Catheter-Associated Bloodstream Infection Treatment Product and Services
Table 16. Citus Pharmaceuticals Catheter-Associated Bloodstream Infection Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Citus Pharmaceuticals Recent Developments/Updates
Table 18. Fresenius Medical Care Basic Information, Manufacturing Base and Competitors
Table 19. Fresenius Medical Care Major Business
Table 20. Fresenius Medical Care Catheter-Associated Bloodstream Infection Treatment Product and Services
Table 21. Fresenius Medical Care Catheter-Associated Bloodstream Infection Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Fresenius Medical Care Recent Developments/Updates
Table 23. Glenmark Pharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. Glenmark Pharmaceuticals Ltd. Major Business
Table 25. Glenmark Pharmaceuticals Ltd. Catheter-Associated Bloodstream Infection Treatment Product and Services
Table 26. Glenmark Pharmaceuticals Ltd. Catheter-Associated Bloodstream Infection Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Glenmark Pharmaceuticals Ltd. Recent Developments/Updates
Table 28. Geistlich Pharma Basic Information, Manufacturing Base and Competitors
Table 29. Geistlich Pharma Major Business
Table 30. Geistlich Pharma Catheter-Associated Bloodstream Infection Treatment Product and Services
Table 31. Geistlich Pharma Catheter-Associated Bloodstream Infection Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Geistlich Pharma Recent Developments/Updates
Table 33. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 34. Merck & Co., Inc. Major Business
Table 35. Merck & Co., Inc. Catheter-Associated Bloodstream Infection Treatment Product and Services
Table 36. Merck & Co., Inc. Catheter-Associated Bloodstream Infection Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Merck & Co., Inc. Recent Developments/Updates
Table 38. Pfizer Basic Information, Manufacturing Base and Competitors
Table 39. Pfizer Major Business
Table 40. Pfizer Catheter-Associated Bloodstream Infection Treatment Product and Services
Table 41. Pfizer Catheter-Associated Bloodstream Infection Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Pfizer Recent Developments/Updates
Table 43. TauroPhar GmbH Basic Information, Manufacturing Base and Competitors
Table 44. TauroPhar GmbH Major Business
Table 45. TauroPhar GmbH Catheter-Associated Bloodstream Infection Treatment Product and Services
Table 46. TauroPhar GmbH Catheter-Associated Bloodstream Infection Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. TauroPhar GmbH Recent Developments/Updates
Table 48. Xellia Pharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors
Table 49. Xellia Pharmaceuticals Ltd. Major Business
Table 50. Xellia Pharmaceuticals Ltd. Catheter-Associated Bloodstream Infection Treatment Product and Services
Table 51. Xellia Pharmaceuticals Ltd. Catheter-Associated Bloodstream Infection Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Xellia Pharmaceuticals Ltd. Recent Developments/Updates
Table 53. Global Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Catheter-Associated Bloodstream Infection Treatment Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Catheter-Associated Bloodstream Infection Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 56. Market Position of Manufacturers in Catheter-Associated Bloodstream Infection Treatment, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Catheter-Associated Bloodstream Infection Treatment Production Site of Key Manufacturer
Table 58. Catheter-Associated Bloodstream Infection Treatment Market: Company Product Type Footprint
Table 59. Catheter-Associated Bloodstream Infection Treatment Market: Company Product Application Footprint
Table 60. Catheter-Associated Bloodstream Infection Treatment New Market Entrants and Barriers to Market Entry
Table 61. Catheter-Associated Bloodstream Infection Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Catheter-Associated Bloodstream Infection Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Catheter-Associated Bloodstream Infection Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Catheter-Associated Bloodstream Infection Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 67. Global Catheter-Associated Bloodstream Infection Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 68. Global Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global Catheter-Associated Bloodstream Infection Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Catheter-Associated Bloodstream Infection Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Catheter-Associated Bloodstream Infection Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 73. Global Catheter-Associated Bloodstream Infection Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 74. Global Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global Catheter-Associated Bloodstream Infection Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Catheter-Associated Bloodstream Infection Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Catheter-Associated Bloodstream Infection Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 79. Global Catheter-Associated Bloodstream Infection Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 80. North America Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Catheter-Associated Bloodstream Infection Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Catheter-Associated Bloodstream Infection Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Catheter-Associated Bloodstream Infection Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Catheter-Associated Bloodstream Infection Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Catheter-Associated Bloodstream Infection Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Catheter-Associated Bloodstream Infection Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Catheter-Associated Bloodstream Infection Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Catheter-Associated Bloodstream Infection Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Catheter-Associated Bloodstream Infection Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Catheter-Associated Bloodstream Infection Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Catheter-Associated Bloodstream Infection Treatment Raw Material
Table 121. Key Manufacturers of Catheter-Associated Bloodstream Infection Treatment Raw Materials
Table 122. Catheter-Associated Bloodstream Infection Treatment Typical Distributors
Table 123. Catheter-Associated Bloodstream Infection Treatment Typical Customers
List of Figures
Figure 1. Catheter-Associated Bloodstream Infection Treatment Picture
Figure 2. Global Catheter-Associated Bloodstream Infection Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Catheter-Associated Bloodstream Infection Treatment Consumption Value Market Share by Type in 2022
Figure 4. Antibacterial Agents Examples
Figure 5. Antibiotic Examples
Figure 6. Global Catheter-Associated Bloodstream Infection Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Catheter-Associated Bloodstream Infection Treatment Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Specialist Clinic Examples
Figure 10. Other Examples
Figure 11. Global Catheter-Associated Bloodstream Infection Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Catheter-Associated Bloodstream Infection Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Catheter-Associated Bloodstream Infection Treatment Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Catheter-Associated Bloodstream Infection Treatment Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Catheter-Associated Bloodstream Infection Treatment Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Catheter-Associated Bloodstream Infection Treatment by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Catheter-Associated Bloodstream Infection Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Catheter-Associated Bloodstream Infection Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Catheter-Associated Bloodstream Infection Treatment Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Catheter-Associated Bloodstream Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Catheter-Associated Bloodstream Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Catheter-Associated Bloodstream Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Catheter-Associated Bloodstream Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Catheter-Associated Bloodstream Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Catheter-Associated Bloodstream Infection Treatment Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Catheter-Associated Bloodstream Infection Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Catheter-Associated Bloodstream Infection Treatment Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Catheter-Associated Bloodstream Infection Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Catheter-Associated Bloodstream Infection Treatment Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Catheter-Associated Bloodstream Infection Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Catheter-Associated Bloodstream Infection Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Catheter-Associated Bloodstream Infection Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Catheter-Associated Bloodstream Infection Treatment Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Catheter-Associated Bloodstream Infection Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Catheter-Associated Bloodstream Infection Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Catheter-Associated Bloodstream Infection Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Catheter-Associated Bloodstream Infection Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Catheter-Associated Bloodstream Infection Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Catheter-Associated Bloodstream Infection Treatment Consumption Value Market Share by Region (2018-2029)
Figure 53. China Catheter-Associated Bloodstream Infection Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Catheter-Associated Bloodstream Infection Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Catheter-Associated Bloodstream Infection Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Catheter-Associated Bloodstream Infection Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Catheter-Associated Bloodstream Infection Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Catheter-Associated Bloodstream Infection Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Catheter-Associated Bloodstream Infection Treatment Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Catheter-Associated Bloodstream Infection Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Catheter-Associated Bloodstream Infection Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Catheter-Associated Bloodstream Infection Treatment Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Catheter-Associated Bloodstream Infection Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Catheter-Associated Bloodstream Infection Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Catheter-Associated Bloodstream Infection Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Catheter-Associated Bloodstream Infection Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Catheter-Associated Bloodstream Infection Treatment Market Drivers
Figure 74. Catheter-Associated Bloodstream Infection Treatment Market Restraints
Figure 75. Catheter-Associated Bloodstream Infection Treatment Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Catheter-Associated Bloodstream Infection Treatment in 2022
Figure 78. Manufacturing Process Analysis of Catheter-Associated Bloodstream Infection Treatment
Figure 79. Catheter-Associated Bloodstream Infection Treatment Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source